// App-Quantinova.ai

3011 : Analysis of Adct-602 Pre-Clinical Activity in B-Cell Lymphoma Models and Identification of Potential Biomarkers for Its Activity

Researchers

Presenter

  • Eugenio Gaudio

Principal Investigators

  • Chiara Tarantelli

  • Luciano Cascione

  • Filippo Spriano

  • Gaetanina Golino

  • Lorenzo Scalise

  • Emanuele Zucca

  • Anastasios Stathis

  • Patrick H Van Berkel

  • Francesca Zammarchi

  • Francesco Bertoni

Medical Centers

  • Institute of Oncology Research, Faculty of Biomedical Sciences,USI,Bellinzona,Switzerland

  • Swiss Institute of Bioinformatics, Lausanne, Switzerland

  • Magna Graecia University, Catanzaro, Italy

  • Institute of Oncology Research, Faculty of Biomedical Sciences,USI,Bellinzona,Switzerland

  • Oncology Institute of Southern Switzerland, Bellinzona, Switzerland

  • Oncology Institute of Southern Switzerland, Bellinzona, Switzerland

  • ADC Therapeutics (UK) Ltd, United Kingdom

  • ADC Therapeutics, London, United Kingdom

Locations

  • Switzerland

  • Italy

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • B cell lymphomas

Biomarkers

  • Apparent diffusion coefficient

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I/II

Study Id's

  • NCT03698552

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved